[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Mixed Late Afternoon",
    "summary": "Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index adding 0.1%",
    "url": "https://finnhub.io/api/news?id=23c19e1db3fa6aa7aa1650e2689e1f433be52d73522c2ed31b8d5231b86c4102",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756323715,
      "headline": "Sector Update: Health Care Stocks Mixed Late Afternoon",
      "id": 136541216,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index adding 0.1%",
      "url": "https://finnhub.io/api/news?id=23c19e1db3fa6aa7aa1650e2689e1f433be52d73522c2ed31b8d5231b86c4102"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna (MRNA) Stock Is Up Today",
    "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.6% in the afternoon session after the company announced it received U.S. Food and Drug Administration (FDA) approval for its updated COVID-19 vaccines for the 2025-2026 season.",
    "url": "https://finnhub.io/api/news?id=6c280f886e525d295f2e4b39f5b50f97df36ac7a08a8f3cf14fabc8f85960e36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756321555,
      "headline": "Why Moderna (MRNA) Stock Is Up Today",
      "id": 136541482,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.6% in the afternoon session after the company announced it received U.S. Food and Drug Administration (FDA) approval for its updated COVID-19 vaccines for the 2025-2026 season.",
      "url": "https://finnhub.io/api/news?id=6c280f886e525d295f2e4b39f5b50f97df36ac7a08a8f3cf14fabc8f85960e36"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Receives US FDA Approval for Updated COVID-19 Vaccines Targeting the LP.8.1 Variant",
    "summary": "Moderna (MRNA) said Wednesday that the US Food and Drug Administration has approved its supplemental",
    "url": "https://finnhub.io/api/news?id=8bb335a52de11eefbfe8ccf4149c69c512d28b8deb50c0709b471b5a23f01a3f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756320855,
      "headline": "Moderna Receives US FDA Approval for Updated COVID-19 Vaccines Targeting the LP.8.1 Variant",
      "id": 136541483,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) said Wednesday that the US Food and Drug Administration has approved its supplemental",
      "url": "https://finnhub.io/api/news?id=8bb335a52de11eefbfe8ccf4149c69c512d28b8deb50c0709b471b5a23f01a3f"
    }
  },
  {
    "ts": null,
    "headline": "RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.",
    "summary": "BioNTech stock skidded Wednesday after the Food and Drug Administration ended its broad authorization of Covid vaccines in the U.S.",
    "url": "https://finnhub.io/api/news?id=1a299388f40e08b9bb9af5c91fbd4c1d220613b271a8129aa57f00d003fff393",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756319149,
      "headline": "RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.",
      "id": 136540038,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "BioNTech stock skidded Wednesday after the Food and Drug Administration ended its broad authorization of Covid vaccines in the U.S.",
      "url": "https://finnhub.io/api/news?id=1a299388f40e08b9bb9af5c91fbd4c1d220613b271a8129aa57f00d003fff393"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2",
    "summary": "CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications (sBLA) for the 2025-2026 formulas for Spikevax® ...",
    "url": "https://finnhub.io/api/news?id=b239ccce008a3a1628dd78041a649ea0fbf37ebd95f35aeb7bf1a6b08660a87e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756315440,
      "headline": "Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2",
      "id": 136540040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications (sBLA) for the 2025-2026 formulas for Spikevax® ...",
      "url": "https://finnhub.io/api/news?id=b239ccce008a3a1628dd78041a649ea0fbf37ebd95f35aeb7bf1a6b08660a87e"
    }
  },
  {
    "ts": null,
    "headline": "New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One.",
    "summary": "The Food and Drug Administration approved shots from Pfizer, Moderna and Novavax, but for a narrower population.",
    "url": "https://finnhub.io/api/news?id=ea4e3f36b47db4a3426c20b44d91dbd2e7c27f056f00c0af8318cb2929301611",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756314720,
      "headline": "New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One.",
      "id": 136539697,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The Food and Drug Administration approved shots from Pfizer, Moderna and Novavax, but for a narrower population.",
      "url": "https://finnhub.io/api/news?id=ea4e3f36b47db4a3426c20b44d91dbd2e7c27f056f00c0af8318cb2929301611"
    }
  },
  {
    "ts": null,
    "headline": "Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'",
    "summary": "The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market \"within months,\" according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr. Shortly after the update, COVID-19 vaccine stocks, ...",
    "url": "https://finnhub.io/api/news?id=77dc9df5cd4ac485649fa3adce84d493276ea01777881d874b79d7f737013cad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756254667,
      "headline": "Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'",
      "id": 136536543,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market \"within months,\" according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr. Shortly after the update, COVID-19 vaccine stocks, ...",
      "url": "https://finnhub.io/api/news?id=77dc9df5cd4ac485649fa3adce84d493276ea01777881d874b79d7f737013cad"
    }
  }
]